After deploying ~$1 billion over a decade across names like Lenskart, PineLabs and Giva, Schroders Capital is doubling down on India with $50 million average tickets in consumer, healthcare, tech and AI — leaning on secondaries and continuation vehicles as exit routes broaden beyond IPOs.

Mint · 5/25/2026, 9:34:49 AM